Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 632326 | ISIN: US3434981011 | Ticker-Symbol: FWF
Tradegate
12.11.24
09:34 Uhr
20,200 Euro
-0,200
-0,98 %
1-Jahres-Chart
FLOWERS FOODS INC Chart 1 Jahr
5-Tage-Chart
FLOWERS FOODS INC 5-Tage-Chart
RealtimeGeldBriefZeit
20,40020,60023:00
20,40020,60021:59
PR Newswire
64 Leser
Artikel bewerten:
(0)

Flowers Foods, Inc. Reports Third Quarter 2024 Results

Finanznachrichten News

THOMASVILLE, Ga., Nov. 8, 2024 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today reported financial results for the company's 12-week third quarter ended October 5, 2024.

Third Quarter Summary:
Compared to the prior year third quarter where applicable

  • Net sales(1) decreased 0.7% to $1.191 billion as positive pricing/mix was more than offset by volume declines.
  • Net income increased $111.7 million to $65.0 million, primarily due to growth in operating income from a decrease in legal settlements and related costs, partially offset by higher net interest expense. Adjusted net income(2) increased 12.4% to $69.3 million.
  • Adjusted EBITDA(2) increased 10.0% to $133.3 million, representing 11.2% of net sales, a 110-basis point increase.
  • Diluted EPS increased $0.53 to $0.31. Adjusted diluted EPS(2) increased $0.04 to $0.33.

Chairman and CEO Remarks:

"Strong performance by our leading brands and successful execution of our cost initiatives and portfolio strategy drove better-than-expected earnings in the third quarter," said Ryals McMullian, chairman and CEO of Flowers Foods. "We handily outpaced the bread category, growing tracked channel sales in both units and dollars. Those results were achieved despite headwinds from a pressured consumer, which also particularly impacted our sweet baked goods and fast food businesses. Additionally, implementation of our portfolio strategy enhanced performance in our away-from-home business, improving profitability of existing business and adding higher margin new accounts.

"We are narrowing our 2024 financial outlook to reflect greater certainty as we enter the fourth quarter and strong relative performance in the branded retail bread category, partially offset by headwinds from consumer and promotional behavior. We also expect continued benefits from new business wins and efficiency initiatives. Beyond 2024, our focus remains on enhancing shareholder value and delivering results consistent with our long-term financial targets."

For the 52-week Fiscal 2024, the Company Expects:

  • Net sales in the range of approximately $5.116 billion to $5.147 billion, representing 0.5% to 1.1% growth compared to the prior year. Prior guidance called for net sales in the range of approximately $5.091 billion to $5.172 billion, representing 0.0% to 1.6% growth.
  • Adjusted EBITDA(3) in the range of approximately $530 million to $542 million, compared to prior guidance of approximately $524 million to $553 million.
  • Adjusted diluted EPS(2) in the range of approximately $1.24 to $1.28, compared to prior guidance of approximately $1.20 to $1.30.

The company's outlook is based on the following assumptions:

  • Depreciation and amortization in the range of $155 million to $160 million.
  • Net interest expense of approximately $20 million to $24 million.
  • An effective tax rate of approximately 25%.
  • Weighted average diluted share count for the year of approximately 212.5 million shares.
  • Capital expenditures in the range of $130 million to $140 million, with $5 million to $7 million related to the ERP upgrade, compared to prior guidance in the range of $145 million to $155 million, with $3 million to $6 million related to the ERP upgrade.

Matters Affecting Comparability:

Reconciliation of Earnings per Share to Adjusted Earnings per Share




For the 12-Week
Period Ended



For the 12-Week
Period Ended




October 5, 2024



October 7, 2023


Net income (loss) per diluted common share


$

0.31



$

(0.22)


Business process improvement costs


NM




0.02


Plant closure costs and impairment of assets



0.02



NM


Restructuring charges



-



NM


Legal settlements and related costs


NM




0.49


Adjusted net income per diluted common share


$

0.33



$

0.29



NM - not meaningful.

Certain amounts may not add due to rounding.

Consolidated Third Quarter Operating Highlights
Compared to the prior year third quarter where applicable

  • Net sales decreased 0.7% to $1.191 billion. Pricing/mix(4) increased 1.7% and volume(5) declined 2.4%.
    • Branded Retail net sales decreased $11.5 million or 1.5% to $760.6 million due to unfavorable price/mix resulting from increased promotional activity, and volume declines. Branded cake drove the volume decrease, partially offset by volume growth in branded bread products. Pricing/mix(4) declined 0.9% and volume(5) decreased 0.6%.
    • Other net sales increased $2.8 million or 0.7% to $430.0 million due to significant favorable price/mix from optimizing our non-retail business, most notably in foodservice, partially offset by volume declines concentrated in vending, foodservice, and institutional sales. Pricing/mix(4) rose 4.9% and volume(5) declined 4.2%.
  • Materials, supplies, labor, and other production costs (exclusive of depreciation and amortization) were 50.2% of net sales, a 130-basis point decrease. These costs decreased as a percentage of net sales due to moderating ingredient and packaging costs, improved net sales price/mix, and decreased product returns. Lower production volumes, higher workforce-related costs, and increased outside purchases of product (sales with no associated ingredient costs) partially offset the overall improvement.
  • Selling, distribution, and administrative (SD&A) expenses were 38.7% of net sales, a 1,170-basis point decrease. SD&A decreased as a percentage of net sales due to significantly lower legal settlements and related costs, as well as lower distributor distribution fees, marketing expense, logistics and freight costs, and consulting costs. These items were partially offset by increased workforce-related costs, higher rent expense, and lower scrap dough income. Excluding matters affecting comparability, adjusted SD&A(2) was 38.6% of net sales, a 20 basis point increase.
  • Legal settlements and related costs were $0.8 million, or 0.1% of net sales, compared to $137.5 million, or 11.5% of net sales in the prior year quarter.
  • The company recognized plant closure costs and asset impairments of $4.5 million, which represented 0.4% of net sales, primarily related to the closure of its Baton Rouge bakery. In the prior year quarter, the company recorded an impairment charge of $1.0 million, or 0.1% of net sales, related to an agreement to sell a warehouse classified as held for sale.
  • Depreciation and amortization (D&A) expenses were $37.3 million or 3.1% of net sales, a 10-basis point increase.
  • Net interest expense increased $0.8 million primarily due to lower interest income resulting from decreases in distributor notes receivable outstanding.
  • Net income increased $111.7 million to $65.0 million. Adjusted net income(2) increased 12.4% to $69.3 million.
  • Adjusted EBITDA(2) increased 10.0% to $133.3 million, representing 11.2% of net sales, a 110-basis point increase.

Cash Flow, Capital Allocation, and Capital Return

Year-to-date, through the third quarter of fiscal 2024, cash flow from operating activities increased $25.1 million to $282.4 million, capital expenditures decreased $10.4 million to $86.6 million, and dividends paid to shareholders increased $5.8 million to $152.5 million. Cash and cash equivalents were $15.0 million at quarter end.

(1)

Any reference to sales refers to net sales inclusive of allowances and deductions against gross sales

(2)

Adjusted for items affecting comparability. See reconciliations of non-GAAP measures in the financial statements following this release. Earnings are net income (loss). EBITDA and Adjusted EBITDA are reconciled to net income (loss).

(3)

No reconciliation of the forecasted range for adjusted EBITDA to net income for the 52-week Fiscal 2024 is included in this press release because the company is unable to quantify certain amounts that would be required to be included in the GAAP measure without unreasonable efforts. In addition, the company believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors.

(4)

Calculated as (current year period units X change in price per unit) / prior year period net sales dollars

(5)

Calculated as (prior year period price per unit X change in units) / prior year period net sales dollars

Pre-Recorded Management Remarks and Question and Answer Webcast
In conjunction with this release, pre-recorded management remarks and a supporting slide presentation will be posted to the Flowers Foods website. The company will host a live question and answer webcast at 8:30 a.m. (Eastern) on November 8, 2024. The pre-recorded remarks and webcast will be archived on the investors page of flowersfoods.com.

About Flowers Foods

Headquartered in Thomasville, Ga., Flowers Foods, Inc. (NYSE: FLO) is one of the largest producers of packaged bakery foods in the United States with 2023 net sales of $5.1 billion. Flowers operates bakeries across the country that produce a wide range of bakery products. Among the company's top brands are Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, and Tastykake. Learn more at www.flowersfoods.com.

FLO-CORP FLO-IR

Forward-Looking Statements

Statements contained in this press release and certain other written or oral statements made from time to time by Flowers Foods, Inc. (the "company", "Flowers Foods", "Flowers", "us", "we", or "our") and its representatives that are not historical facts are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to current expectations regarding our business and our future financial condition and results of operations and are often identified by the use of words and phrases such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "would," "is likely to," "is expected to" or "will continue," or the negative of these terms or other comparable terminology. These forward-looking statements are based upon assumptions we believe are reasonable. Forward-looking statements are based on current information and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected. Certain factors that may cause actual results, performance, liquidity, and achievements to differ materially from those projected are discussed in our Annual Report on Form 10-K for the year ended December 30, 2023 (the "Form 10-K") and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission ("SEC") and may include, but are not limited to, (a) unexpected changes in any of the following: (1) general economic and business conditions; (2) the competitive setting in which we operate, including advertising or promotional strategies by us or our competitors, as well as changes in consumer demand; (3) interest rates and other terms available to us on our borrowings; (4) supply chain conditions and any related impact on energy and raw materials costs and availability and hedging counter-party risks; (5) relationships with or increased costs related to our employees and third-party service providers; (6) laws and regulations (including environmental and health-related issues); and (7) accounting standards or tax rates in the markets in which we operate, (b) the loss or financial instability of any significant customer(s), including as a result of product recalls or safety concerns related to our products, (c) changes in consumer behavior, trends and preferences, including health and whole grain trends, and the movement toward less expensive store branded products, (d) the level of success we achieve in developing and introducing new products and entering new markets, (e) our ability to implement new technology and customer requirements as required, (f) our ability to operate existing, and any new, manufacturing lines according to schedule, (g) our ability to implement and achieve our corporate responsibility goals in accordance with regulatory requirements and expectations of stakeholders, suppliers, and customers; (h) our ability to execute our business strategies which may involve, among other things, (1) the ability to realize the intended benefits of completed, planned or contemplated acquisitions, dispositions or joint ventures, (2) the deployment of new systems (e.g., our enterprise resource planning ("ERP") system), distribution channels and technology, and (3) an enhanced organizational structure (e.g., our sales and supply chain reorganization), (i) consolidation within the baking industry and related industries, (j) changes in pricing, customer and consumer reaction to pricing actions (including decreased volumes), and the pricing environment among competitors within the industry, (k) our ability to adjust pricing to offset, or partially offset, inflationary pressure on the cost of our products, including ingredient and packaging costs; (l) disruptions in our direct-store-delivery distribution model, including litigation or an adverse ruling by a court or regulatory or governmental body that could affect the independent contractor classifications of the independent distributor partners, and changes to our direct-store-delivery distribution model in California, (m) increasing legal complexity and legal proceedings that we are or may become subject to, (n) labor shortages and turnover or increases in employee and employee-related costs, (o) the credit, business, and legal risks associated with independent distributor partners and customers, which operate in the highly competitive retail food and foodservice industries, (p) any business disruptions due to political instability, pandemics, armed hostilities (including the ongoing conflict between Russia and Ukraine and the conflict in the Middle East), incidents of terrorism, natural disasters, labor strikes or work stoppages, technological breakdowns, product contamination, product recalls or safety concerns related to our products, or the responses to or repercussions from any of these or similar events or conditions and our ability to insure against such events, (q) the failure of our information technology systems to perform adequately, including any interruptions, intrusions, cyber-attacks or security breaches of such systems or risks associated with the implementation of the upgrade of our ERP system; and (r) the potential impact of climate change on the company, including physical and transition risks, availability or restriction of resources, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms. The foregoing list of important factors does not include all such factors, nor does it necessarily present them in order of importance. In addition, you should consult other disclosures made by the company (such as in our other filings with the SEC or in company press releases) for other factors that may cause actual results to differ materially from those projected by the company. Refer to Part I, Item 1A., Risk Factors, of the Form 10-K, Part II, Item 1A., Risk Factors, of the Form 10-Q for the quarter ended October 5, 2024 and subsequent filings with the SEC for additional information regarding factors that could affect the company's results of operations, financial condition and liquidity. We caution you not to place undue reliance on forward-looking statements, as they speak only as of the date made and are inherently uncertain. The company undertakes no obligation to publicly revise or update such statements, except as required by law. You are advised, however, to consult any further public disclosures by the company (such as in our filings with the SEC or in company press releases) on related subjects.

Information Regarding Non-GAAP Financial Measures

The company prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP). However, from time to time, the company may present in its public statements, press releases and SEC filings, non-GAAP financial measures such as, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense, adjusted selling, distribution and administrative expenses (SD&A), and gross margin excluding depreciation and amortization. The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure. The company's definitions of these non-GAAP measures may differ from similarly titled measures used by others. These non-GAAP measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.

The company defines EBITDA as earnings before interest, taxes, depreciation and amortization. Earnings are net income. The company believes that EBITDA is a useful tool for managing the operations of its business and is an indicator of the company's ability to incur and service indebtedness and generate free cash flow. The company also believes that EBITDA measures are commonly reported and widely used by investors and other interested parties as measures of a company's operating performance and debt servicing ability because EBITDA measures assist in comparing performance on a consistent basis without regard to depreciation or amortization, which can vary significantly depending upon accounting methods and non-operating factors (such as historical cost). EBITDA is also a widely-accepted financial indicator of a company's ability to incur and service indebtedness.

EBITDA should not be considered an alternative to (a) income from operations or net income (loss) as a measure of operating performance; (b) cash flows provided by operating, investing and financing activities (as determined in accordance with GAAP) as a measure of the company's ability to meet its cash needs; or (c) any other indicator of performance or liquidity that has been determined in accordance with GAAP.

The company defines adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted diluted EPS, adjusted income tax expense and adjusted SD&A, respectively, to exclude additional costs that the company considers important to present to investors to increase the investors' insights about the company's core operations. These costs include, but are not limited to, the costs of closing a plant or costs associated with acquisition-related activities, restructuring activities, certain impairment charges, legal settlements, costs to implement an enterprise resource planning system and enhance bakery digital capabilities (business process improvement costs) to provide investors direct insight into these costs, and other costs impacting past and future comparability. The company believes that these measures, when considered together with its GAAP financial results, provides management and investors with a more complete understanding of its business operating results, including underlying trends, by excluding the effects of certain charges. Adjusted EBITDA is used as the primary performance measure in the company's 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023).

Presentation of gross margin includes depreciation and amortization in the materials, supplies, labor and other production costs according to GAAP. Our method of presenting gross margin excludes the depreciation and amortization components, as discussed above.

The reconciliations attached provide reconciliations of the non-GAAP measures used in this release to the most comparable GAAP financial measure.

Flowers Foods, Inc.

Condensed Consolidated Balance Sheets

(000's omitted)




October 5, 2024



December 30, 2023


Assets







Cash and cash equivalents


$

14,975



$

22,527


Other current assets



676,506




655,422


Property, plant and equipment, net



947,702




962,981


Right-of-use leases, net



308,995




276,864


Distributor notes receivable (1)



128,576




133,335


Other assets



39,765




40,286


Cost in excess of net tangible assets, net



1,313,440




1,335,538


Total assets


$

3,429,959



$

3,426,953


Liabilities and Stockholders' Equity







Current liabilities


$

504,388



$

611,546


Long-term debt



1,054,143




1,048,144


Right-of-use lease liabilities (2)



315,803




284,501


Other liabilities



149,099




130,980


Stockholders' equity



1,406,526




1,351,782


Total liabilities and stockholders' equity


$

3,429,959



$

3,426,953











(1)

Includes current portion of $16,243 and $9,764, respectively.

(2)

Includes current portion of $64,673 and $47,606, respectively.

Flowers Foods, Inc.

Consolidated Statement of Operations

(000's omitted, except per share data)




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Net sales


$

1,190,561



$

1,199,260



$

3,992,362



$

3,961,803


Materials, supplies, labor and other production costs (exclusive of
depreciation and amortization shown separately below)



598,209




617,468




2,008,757




2,044,417


Selling, distribution, and administrative expenses



460,359




603,954




1,557,010




1,671,813


Restructuring charges



-




179




7,403




6,873


Plant closure costs and impairment of assets



4,483




1,034




9,860




1,034


Depreciation and amortization expense



37,331




35,974




122,393




114,693


Income (loss) from operations



90,179




(59,349)




286,939




122,973


Other pension benefit



(119)




(62)




(395)




(207)


Interest expense, net



4,778




4,010




15,297




12,147


Income (loss) before income taxes



85,520




(63,297)




272,037




111,033


Income tax expense (benefit)



20,536




(16,567)




67,043




23,293


Net income (loss)


$

64,984



$

(46,730)



$

204,994



$

87,740


Net income (loss) per diluted common share


$

0.31



$

(0.22)



$

0.97



$

0.41


Diluted weighted average shares outstanding



211,975




211,522




212,123




213,455


Flowers Foods, Inc.

Condensed Consolidated Statement of Cash Flows

(000's omitted)




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Cash flows from operating activities:













Net income (loss)


$

64,984



$

(46,730)



$

204,994



$

87,740


Adjustments to reconcile net income (loss) to net cash from operating
activities:













Total non-cash adjustments



58,273




6,458




182,843




111,814


Changes in assets and liabilities and pension plan contributions



(9,308)




168,683




(105,467)




57,764


Net cash provided by operating activities



113,949




128,411




282,370




257,318


Cash flows from investing activities:













Purchase of property, plant and equipment



(25,373)




(28,618)




(86,624)




(97,003)


Proceeds from sale of property, plant and equipment



1,231




1,503




2,040




2,278


Acquisition of business



-




-




-




(274,755)


Investment in unconsolidated affiliate



-




-




-




(1,981)


Other



(12,295)




(1,051)




(28,358)




4,926


Net cash disbursed for investing activities



(36,437)




(28,166)




(112,942)




(366,535)


Cash flows from financing activities:













Dividends paid



(50,543)




(48,603)




(152,489)




(146,726)


Stock repurchases



-




(4,647)




(22,703)




(30,891)


Net change in debt borrowings



(15,000)




(37,000)




5,000




145,000


Payments on financing leases



(66)




(461)




(235)




(1,513)


Other



(3,794)




(6,684)




(6,553)




(7,226)


Net cash disbursed for financing activities



(69,403)




(97,395)




(176,980)




(41,356)


Net increase (decrease) in cash and cash equivalents



8,109




2,850




(7,552)




(150,573)


Cash and cash equivalents at beginning of period



6,866




11,711




22,527




165,134


Cash and cash equivalents at end of period


$

14,975



$

14,561



$

14,975



$

14,561


Flowers Foods, Inc.

Net Sales by Sales Class and Net Sales Bridge

(000's omitted)


Net Sales by Sales Class


Net Sales by Sales Class


For the 12-Week Period
Ended



For the 12-Week Period
Ended










October 5, 2024



October 7, 2023



$ Change



% Change


Branded Retail


$

760,580



$

772,082



$

(11,502)




(1.5)

%

Other



429,981




427,178




2,803




0.7

%

Total Net Sales


$

1,190,561



$

1,199,260



$

(8,699)




(0.7)

%


Net Sales by Sales Class


For the 40-Week Period
Ended



For the 40-Week Period
Ended










October 5, 2024



October 7, 2023



$ Change



% Change


Branded Retail


$

2,565,310



$

2,539,890



$

25,420




1.0

%

Other



1,427,052




1,421,913




5,139




0.4

%

Total Net Sales


$

3,992,362



$

3,961,803



$

30,559




0.8

%

Net Sales Bridge


For the 12-week period ended October 5, 2024


Branded Retail



Other



Total


Pricing/mix*



(0.9)

%



4.9

%



1.7

%

Volume*



(0.6)

%



(4.2)

%



(2.4)

%

Total percentage point change in net sales



(1.5)

%



0.7

%



(0.7)

%


For the 40-week period ended October 5, 2024


Branded Retail



Other



Total


Pricing/mix*



0.9

%



3.2

%



2.0

%

Volume*



(0.1)

%



(3.0)

%



(1.4)

%

Acquisition until cycled on February 17, 2024



0.2

%



0.2

%



0.2

%

Total percentage point change in net sales



1.0

%



0.4

%



0.8

%













* Computations above are calculated as follows (the Total column is consolidated and is not adding the Branded Retail and Other columns):


Price/Mix $ = Current year period units × change in price per unit


Price/Mix % = Price/Mix $ ÷ Prior year period Net Sales $












Volume $ = Prior year period price per unit × change in units


Volume % = Volume $ ÷ Prior year period Net Sales $


Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Earnings (Loss) per Share to Adjusted Earnings per Share




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Net income (loss) per diluted common share


$

0.31



$

(0.22)



$

0.97



$

0.41


Business process improvement costs


NM




0.02




0.02




0.07


Plant closure costs and impairment of assets



0.02



NM




0.03



NM


Restructuring charges



-



NM




0.03




0.02


Restructuring-related implementation costs



-




-




0.01




-


Acquisition-related costs



-




-




-




0.01


Legal settlements and related costs


NM




0.49



NM




0.48


Adjusted net income per diluted common share


$

0.33



$

0.29



$

1.06



$

1.00


NM - not meaningful.













Certain amounts may not add due to rounding.















Reconciliation of Gross Margin




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Net sales


$

1,190,561



$

1,199,260



$

3,992,362



$

3,961,803


Materials, supplies, labor and other production costs (exclusive
of depreciation and amortization)



598,209




617,468




2,008,757




2,044,417


Gross margin excluding depreciation and amortization



592,352




581,792




1,983,605




1,917,386


Less depreciation and amortization for production activities



20,914




19,225




67,581




62,932


Gross margin


$

571,438



$

562,567



$

1,916,024



$

1,854,454


Depreciation and amortization for production activities


$

20,914



$

19,225



$

67,581



$

62,932


Depreciation and amortization for selling, distribution, and
administrative activities



16,417




16,749




54,812




51,761


Total depreciation and amortization


$

37,331



$

35,974



$

122,393



$

114,693




Reconciliation of Selling, Distribution, and Administrative Expenses to
Adjusted SD&A




For the 12-Week
Period Ended



For the 12-Week Period
Ended



For the 40-Week
Period Ended



For the 40-Week Period
Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Selling, distribution, and administrative expenses
(SD&A)


$

460,359



$

603,954



$

1,557,010



$

1,671,813


Business process improvement costs



(490)




(5,814)




(5,779)




(18,621)


Restructuring-related implementation costs



-




-




(2,979)




-


Acquisition-related costs



-




-




-




(3,712)


Legal settlements and related costs



(827)




(137,529)




(827)




(137,529)


Adjusted SD&A


$

459,042



$

460,611



$

1,547,425



$

1,511,951


Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Net income (loss)


$

64,984



$

(46,730)



$

204,994



$

87,740


Income tax expense (benefit)



20,536




(16,567)




67,043




23,293


Interest expense, net



4,778




4,010




15,297




12,147


Depreciation and amortization



37,331




35,974




122,393




114,693


EBITDA



127,629




(23,313)




409,727




237,873


Other pension benefit



(119)




(62)




(395)




(207)


Business process improvement costs



490




5,814




5,779




18,621


Plant closure costs and impairment of assets



4,483




1,034




9,860




1,034


Restructuring charges



-




179




7,403




6,873


Restructuring-related implementation costs



-




-




2,979




-


Acquisition-related costs



-




-




-




3,712


Legal settlements and related costs



827




137,529




827




137,529


Adjusted EBITDA


$

133,310



$

121,181



$

436,180



$

405,435


Net sales


$

1,190,561



$

1,199,260



$

3,992,362



$

3,961,803


Adjusted EBITDA margin



11.2

%



10.1

%



10.9

%



10.2

%



Reconciliation of Income Tax Expense (Benefit) to Adjusted Income Tax Expense




For the 12-Week
Period Ended



For the 12-Week Period
Ended



For the 40-Week
Period Ended



For the 40-Week Period
Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Income tax expense (benefit)


$

20,536



$

(16,567)



$

67,043



$

23,293


Tax impact of:













Business process improvement costs



123




1,453




1,445




4,655


Plant closure costs and impairment of assets



1,122




259




2,466




259


Restructuring charges



-




45




1,851




1,718


Restructuring-related implementation costs



-




-




745




-


Acquisition-related costs



-




-




-




928


Legal settlements and related costs



207




34,382




207




34,382


Adjusted income tax expense


$

21,988



$

19,572



$

73,757



$

65,235


Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(000's omitted, except per share data)




Reconciliation of Net Income (Loss) to Adjusted Net Income




For the 12-Week
Period Ended



For the 12-Week
Period Ended



For the 40-Week
Period Ended



For the 40-Week
Period Ended




October 5, 2024



October 7, 2023



October 5, 2024



October 7, 2023


Net income (loss)


$

64,984



$

(46,730)



$

204,994



$

87,740


Business process improvement costs



367




4,361




4,334




13,966


Plant closure costs and impairment of assets



3,361




775




7,394




775


Restructuring charges



-




134




5,552




5,155


Restructuring-related implementation costs



-




-




2,234




-


Acquisition-related costs



-




-




-




2,784


Legal settlements and related costs



620




103,147




620




103,147


Adjusted net income


$

69,332



$

61,687



$

225,128



$

213,567




Reconciliation of Earnings per Share -
Full Year Fiscal 2024 Guidance




Range Estimate


Net income per diluted common share


$

1.15


to

$

1.19


Business process improvement costs



0.02




0.02


Plant closure costs and impairment of assets



0.03




0.03


Restructuring charges



0.03




0.03


Restructuring-related implementation costs



0.01




0.01


Legal settlements and related costs


NM



NM


Adjusted net income per diluted common share


$

1.24


to

$

1.28


NM - not meaningful.







Certain amounts may not add due to rounding.







SOURCE Flowers Foods, Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.